TZ9

Item no.	TMO-T17187-100mg
Manufacturer	TargetMol
CASRN	1002789-86-7
Amount	100 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Smiles	Nc1nc(COC(=O)c2ccc(cc2)[N+]([O-])=O)nc(Nc2ccccc2)n1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	1002789-86-7
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|E1/E2/E3 Enzyme
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	366.33
Description	TZ9 is a selective and potent Rad6 inhibitor with anticancer and anti-tumor activity.TZ9 inhibits Rad6B-induced ubiquitination of histone H2A.TZ9 induces cell cycle arrest and apoptosis.
Pathways	Ubiquitination\|\|\|Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T17187-100mg-datasheet.pdf

TMO-T17187-100mg-safety-datasheet.pdf